Invention Grant
- Patent Title: Water dissolvable macrocyclic lactone cyclodextrin complexes
-
Application No.: US17094297Application Date: 2020-11-10
-
Publication No.: US11638714B2Publication Date: 2023-05-02
- Inventor: Michael Farber
- Applicant: MOUNTAIN VALLEY MD INC
- Applicant Address: CA Vaughan
- Assignee: MOUNTAIN VALLEY MD INC
- Current Assignee: MOUNTAIN VALLEY MD INC
- Current Assignee Address: CA Vaughan
- Agency: Feigin and Fridman
- Agent Michael J. Feigin, Esq.
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K47/69 ; A61K9/00 ; A61K47/26 ; A61K9/127 ; A61K9/08

Abstract:
Injectable Ivermectin solution is safely administrable to humans and animals used the disclosed technology. A macrocyclic lactone cyclodextrin complex which is completely dissolvable or dissolved in water in a ratio of at least 10-20 milligrams of the macrocyclic lactone complex per 5 milliliters of water. The macrocyclic lactone cyclodextrin complex is non-toxic, without using organic solvents, and in embodiments, formed by adding a surfactant to the macrocyclic lactone complex to water. The macrocyclic lactone cyclodextrin complex is Ivermectin or an Ivermectin derivative in some embodiments. The cyclodextrin complex is 2-hydroxypropyl-beta-cyclodextrin in some embodiments of the disclosed technology. The surfactant can be polysorbate 80 and is in a ratio of 0.01% to 25%, by weight, to said water. The water soluble complexes can be added to the water. The water-soluble complexes can have at least one of an anti-parasitic, anti-viral and anti-cancer complex.
Public/Granted literature
- US20220143057A1 Water Dissolvable Macrocyclic Lactone Cyclodextrin Complexes Public/Granted day:2022-05-12
Information query